Abbott Laboratories (ABT)
Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: United States
Exchange: NYSE
Market cap: $176.90B
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Latest financial period: March 31, 2026
Filed with the SEC: April 29, 2026
Estimated earnings date: October 21, 2026
Profit #691 of 1484 companies
| | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|
| ROIC | 10.5% | 12.0% | 14.0% | 13.6% |
Growth #981 of 1484 companies
Payout #396 of 1484 companies
Safety #64 of 1484 companies
Price #776 of 1484 companies
